APTO
Aptose Biosciences, Inc.
APTO
APTO
Delisted
APTO was delisted on the 1st of April, 2025.
12 hedge funds and large institutions have $264K invested in Aptose Biosciences, Inc. in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$46K | |
| 2 | +$45K | |
| 3 | +$19K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$5.33K | |
| 3 | -$3.83K | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$2.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |